| Home | E-Submission | Sitemap | Contact Us |  
   
ORIGINAL ARTICLE 2022 June 30
Topiramate in an Experimental Model of Epilepsy - Similarity between Generic, Similar and Reference Drugs
Background and Purpose: The literature is still controversial in relation to therapeutic differences between innovative, generic, and similar anti-seizures medications (ASM). Topiramate (TPM) is an ASM used in the treatment of various seizure types and in different epileptic syn...
ORIGINAL ARTICLE 2022 June 30
Perampanel as First Adjunctive Treatment in Patients with Focal-Onset Seizures in the FAME Study: Post hoc Analyses of Dose-Related Efficacy, Safety and Clinical Factors Associated with Response
Background and Purpose: Perampanel is approved for the adjunctive treatment of focal-onset seizures (FOS) with or without secondary generalized seizures. The FAME (Fycompa® as first Add-on to Monotherapy in patients with Epilepsy; NCT02726074) study evaluated the effi...
ORIGINAL ARTICLE 2022 June 30
Perampanel as First Add-On Therapy in Patients with Focal-Onset Seizures in the FAME Trial: Post hoc Analyses of Efficacy and Safety Related to Maintenance Dose and Background Antiepileptic Drug Therapy
Background and Purpose: FAME (Fycompa® as first Add-on to Monotherapy in patients with Epilepsy; NCT02726074), a previously reported single-arm, phase IV study, showed that perampanel improved seizure control as first add-on to failed anti-seizure medication (ASM) mon...
If anyone registers his/her email address, he or she will receive the email of notification when new paper is published in the web site of JER.
Please Sign up.
eISSN : 2233-6257
pISSN : 2233-6249
Current Issue
Volume 12(1); Jun 2022
RSS feed
Original Articles
1 Topiramate in an Experimental Model of Epilepsy - Similarity between Generic, Similar and Reference Drugs
George Linard Silva Malveira, Sacha Aubrey Alves Rodrigues Santos, Gerlânia de Oliveira Leite, Gdayllon Cavalcante Meneses, Adriana Rolim Campos
J Epilepsy Res. 2022;12(1):1-5.   Published online June 30, 2022     DOI: https://doi.org/10.14581/jer.22001
                  
6 Perampanel as First Adjunctive Treatment in Patients with Focal-Onset Seizures in the FAME Study: Post hoc Analyses of Dose-Related Efficacy, Safety and Clinical Factors Associated with Response
Dong Wook Kim, Ji Hyun Kim, Sang Kun Lee, Sang Ahm Lee, Ji Woong Lee, Min Young Kim, Dae-Won Seo
J Epilepsy Res. 2022;12(1):6-12.   Published online June 30, 2022     DOI: https://doi.org/10.14581/jer.22002
                  
13 Perampanel as First Add-On Therapy in Patients with Focal-Onset Seizures in the FAME Trial: Post hoc Analyses of Efficacy and Safety Related to Maintenance Dose and Background Antiepileptic Drug Therapy
Ji Hyun Kim, Dong Wook Kim, Sang Kun Lee, Dae-Won Seo, Ji Woong Lee, Min Young Kim, Sang Ahm Lee
J Epilepsy Res. 2022;12(1):13-20.   Published online June 30, 2022     DOI: https://doi.org/10.14581/jer.22003
                  
21 Psychiatric Comorbidities in Epilepsy
Carlos Arteaga Rodríguez, Mariana Menine Kubis, Carlos Bruno Teixeira Arteaga, Otto Jesus Hernandez Fustes
J Epilepsy Res. 2022;12(1):21-26.   Published online June 30, 2022     DOI: https://doi.org/10.14581/jer.22004
                  
27 Anti-Epileptic Drugs in Geriatric Neurosurgery: A Review of 669 Neurosurgical Cases
Omar Al-Taei, Abdulrahman Al-Mirza, Humaid Al Kalbani, Mohammed Ali, Tariq Al-Saadi
J Epilepsy Res. 2022;12(1):27-32.   Published online June 30, 2022     DOI: https://doi.org/10.14581/jer.22005
                  
Case Reports
33 Epilepsy and Hearing Loss in a Patient with a Rare Heterozygous Variant in the CACNA1H Gene
Hussein A. Algahtani, Bader H. Shirah, Ahmed Samman, Abdulellah Alhazmi
J Epilepsy Res. 2022;12(1):33-35.   Published online June 30, 2022     DOI: https://doi.org/10.14581/jer.22006
                  
36 Successful Treatment of Patient with Lennox-Gastaut Syndrome with Combination of Levetiracetam, Lamotrigine and Valproate after Failure of Corpus Callosotomy
Mohammad Amin Farzi
J Epilepsy Res. 2022;12(1):36-38.   Published online June 30, 2022     DOI: https://doi.org/10.14581/jer.22007
                  
Volume12 No. 1
Author's Index
Author's Index
Manuscript Submission
To submit a manuscript, please visit the J Epilepsy Res e-submission management system at http://submit.j-epilepsy.org, read the Instructions for Authors, and log into the J Epilepsy Res e-submission system. For assistance with manuscript submission, please contact: 40403@snuh.org.
Free archive
Anyone may access any past or current articles without logging in.
Editorial Office
KCC Parktown 101-308, Mallijae-ro 185, Jung-Gu, Seoul, Korea
TEL : +82-2072-2237   FAX : +82-2-362-9663   E-mail : 40403@snuh.org

Copyright© Korean Epilepsy Society.              Developed in M2PI
About |  Browse Articles |  Current Issue |  For Authors and Reviewers